Home > News > Nanotech Zeroes in on the Pharmaceutical Industry
March 9th, 2006
Nanotech Zeroes in on the Pharmaceutical Industry
Abstract:
Jack Uldrich: I am in Dallas today speaking to the AmericansourceBergen Specialty Group about nanotechnology and its implications for the pharmaceutical sector. Therefore my mind has been focused on pharmaceutical applications for the past few days. Two recent developments have caught my attention and they could have implications for nanotech investors.
Source:
NanoNovus
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||